|
Model Number E100-29M |
Device Problems
Calcified (1077); Off-Label Use (1494); Central Regurgitation (4068)
|
Patient Problems
Dyspnea (1816); Tricuspid Valve Insufficiency/ Regurgitation (4453)
|
Event Date 09/08/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
|
Event Description
|
It was reported that 3 years ago on an unknown date, a 29mm stented porcine,mit,epic was implanted in a patient.The patient reported to have dyspean six month prior to the explant procedure.The patient had vena cava filter due to a venous thrombosis and the device migrated to the heart.When the physician tried to recover it, it got stuck in the native tricuspid valve and ruptured causing sudden severe insufficiency and shock in the patient.An emergency surgery was done on 08 september 2023.The valve was explanted due to calcium noted on the valve, and severe valve regurgitation.A 25mm sjm masters series mechanical heart valve device was implanted as a replacement.The reason why a biological valve was implanted at the time was because the patient did not want to be anticoagulated due to sports issues.The patient remain stable.
|
|
Manufacturer Narrative
|
Explant of the device after 3 years due to insufficiency, regurgitation, and fixed leaflets was reported.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.A more comprehensive assessment, including histopathological examination of the valve tissue could not be performed as the device was not returned for analysis.Information from the field indicated that the valve was implanted in the tricuspid position.It was also reported that the valve was calcified, which could have contributed to the reported event.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
|
|
Manufacturer Narrative
|
A valve initially implanted to address thrombosis was explanted due to dyspnea, calcification and severe regurgitation was reported.A more comprehensive assessment, including histopathological examination of the valve tissue could not be performed as the device was not returned for analysis.The provided images illustrate pannus present on the valve outflow surface, potentially causing difficulty of leaflet opening, along with torn leaflets.The cause of torn leaflets remains uncertain, whether they occurred during process of implant or explant of the valve.Calcification and regurgitation were noted, which could have contribute to leaflet tears formation.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The cause of reported incident could not be conclusively determined, but classification of the valve may have contributed to the reported event.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
|
|
Event Description
|
It was reported that in approximately 2020, a 29mm epic mitral valve chosen for implant.The patient had an unrelated procedure for a vena cava filter due to a venous thrombosis, and the device migrated to the heart.When the physician tried to recover the filter, it got stuck in the native tricuspid valve and ruptured, causing sudden severe insufficiency and shock in the patient.The 29mm epic mitral valve was implanted in an emergency surgery in approximately 2020.It was later reported that the patient began having dyspnea in approximately (b)(6) 2023.On (b)(6) 2023, the valve was explanted due to calcification and severe valve regurgitation.A 25mm sjm masters series mechanical heart valve was implanted as a replacement device.The patient remain stable.
|
|
Search Alerts/Recalls
|
|
|